Navigation Links
'Cash For Crow's Feet' Program Offers Effective - and Affordable - Laser Skin Treatments
Date:9/9/2009

ATLANTA, Sept 9 /PRNewswire/ -- The government's "Cash for Clunkers" program may have ended, but financial incentives for improving health and appearance are still available.

Georgia's DeKalb Surgical Associates' "Cash for Crow's Feet" program offers a top-of-the-line skin rejuvenation and repair procedure - fractional laser treatment - at half the typical cost, said Dr. David R. Fern, FACS. Dr. Fern and the Vein & Skin Laser Center are affiliated with DeKalb Surgical Associates, a multi-specialty practice in the Atlanta area that serves patients throughout the southeast. "Our 'whole-face at half-off' philosophy is in response to all the factors at play in the current economic environment," said Dr. Fern. "Patients who may have lost their jobs or are 'reinventing' themselves in new positions or as entrepreneurs starting new businesses need to look their best. And some are using this opportunity to treat long-standing skin and vein problems that need medically correcting."

The American Society of Plastic Surgeons reported recently that professional women, in particular, see procedures such as skin rejuvenation treatments as "employment insurance" to stay or become competitive in their careers. Total cosmetic procedures and minimally-invasive cosmetic procedures have increased since 2007 (3% and 5%, respectively), while more involved surgical cosmetic procedures are down 9% overall. (See http://www.prnewswire.com/mnr/aacs/36867/) "Staying youthful-looking is still a priority for people," said Dr. Fern, "especially when the treatment options are effective - and affordable."

One of the more popular skin rejuvenation treatments available today is the minimally-invasive fractional laser treatment ActiveFX, which uses the latest-generation Lumenis laser. The procedure is used to treat scars, age spots, melasma ("mask of pregnancy"), and wrinkles. A high-energy laser beam interacts with the skin's surface, causing the upper layer to peel off and regenerate a layer of new, healthy skin. The "fractional" pattern leaves small bridges of untouched skin, resulting in a much quicker healing process. "For most patients, ActiveFX can be done on the entire face with one treatment lasting less than an hour," said Dr. Fern.

Fractional laser treatments range from $2,000 to $6,000 nationwide. DeKalb Surgical Associates' "Cash for Crow's Feet" incentive offers the ActiveFX treatment for $1,750, compared to its normal cost of $3,500.

Dr. Fern and the Center also offer several types of non-surgical treatments for vein problems, including the VNUS Closure radio-frequency procedure (as seen on "Good Morning America" on September 3, 2009), laser therapy, and injection schlerotherapy. Dr. Fern is a Fellow of the American College of Surgeons and was in the charter class for Board certification in phlebology, which has only 248 diplomates nationwide. He has been involved in the treatment of skin diseases, skin cancer, melanoma, and vein surgery for 30 years.

The Center offers a free initial consultation with Dr. Fern and certified aesthetician Jigna Naik. For more information, call 404-508-4320.


'/>"/>
SOURCE DeKalb Surgical Associates
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Hard to Treat Diseases, Inc. (HTDS) and Landstar Inc (LDSR) Cash Reward
2. MedQuist Announces Establishment of Revolving Credit Facility and Payment of Special Cash Dividend
3. Endo Pharmaceuticals Announces Cash Tender Offer for Any and All Outstanding Ledgemont PhaRMA(SM) Secured 16% Notes
4. Perrigo Reports Record Sales, Earnings and Cash Flow From Operations for Fiscal 2009
5. CA$H-First(SM) LTCi Provides First-Day Cash Benefits at Affordable Rates
6. Service Corporation International Declares Quarterly Cash Dividend
7. Quest Diagnostics Declares Quarterly Cash Dividend
8. Unilens Vision Inc. Declares Regular Quarterly Cash Dividend of U.S. $0.09 Per Share
9. STAAR Surgical Generates Cash From Operations During Second Quarter
10. Duane Reade Holdings, Inc. Amends Terms and Extends Deadlines for Previously Announced Cash Tender Offers for Senior Secured Floating Rate Notes and Senior Subordinated Notes
11. Webmedx Appoints New Senior Vice President of Client Development, Chris Cashwell
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
(Date:6/24/2016)... Norcross, Georgia (PRWEB) , ... June 24, 2016 ... ... Year” awards today at the Clinical Decision Making in Emergency Medicine conference in ... who have authored journal articles published in Emergency Medicine Practice and ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, ... economy by obtaining investment capital for emerging technology companies. SCP has delivered ... already resulted in more than a million dollars of capital investment for five ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... for human induced pluripotent stem (iPS) cells and other difficult to transfect cells, ... Cloning Medium. The PluriQ™ G9™ Gene Editing System is a complete ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... Forecast to 2022" report to their offering. ... the patients with kidney failure, it replaces the function of ... patient,s blood and thus the treatment helps to keep the ... balance. Increasing number of ESRD patients & ...
Breaking Medicine Technology: